. While the mechanisms responsible for VIDD are not fully understood, recent data reveal that prolonged MV activates autophagy in the diaphragm, which may occur as a result of increased cellular reactive oxygen species (ROS) production. Therefore, we tested the hypothesis that (1) accelerated autophagy is a key contributor to VIDD; and that (2) oxidative stress is required to increase the expression of autophagy genes in the diaphragm. Our findings reveal that targeted inhibition of autophagy in the rat diaphragm prevented MV-induced muscle atrophy and contractile dysfunction. Attenuation of VIDD in these animals occurred as a result of increased diaphragm concentration of the antioxidant catalase and reduced mitochondrial ROS emission, which corresponded to reductions in the activity of calpain and caspase-3. To determine if increased ROS production is required for the upregulation of autophagy biomarkers in the diaphragm, rats that were administered the mitochondrial-targeted peptide SS-31 during MV. Results from this study demonstrated that mitochondrial ROS production in the diaphragm during MV is required for the increased expression of key autophagy genes (i.e. LC3, Atg7, Atg12, Beclin1 and p62), as well as for increased activity of cathepsin L. Together, these data reveal that autophagy is required for VIDD, and that autophagy inhibition reduces MV-induced diaphragm ROS production and prevents a positive feedback loop whereby increased autophagy is stimulated by oxidative stress, resulting in further increases in ROS and autophagy.
Introduction
Mechanical ventilation (MV) is used to maintain adequate alveolar ventilation in patients unable to maintain blood gas homeostasis with spontaneous breathing. While MV is a life-saving intervention for critically ill patients, prolonged MV results in the rapid development of diaphragm weakness due to both myofiber atrophy and contractile dysfunction; this condition is termed ventilator-induced diaphragm dysfunction (VIDD) [1] [2] [3] . VIDD is important because diaphragm weakness is predicted to contribute to difficulties in weaning patients from the ventilator [4] [5] [6] . Unfortunately, there is currently no standard therapy to prevent VIDD. Therefore, improving our understanding of the cellular processes that promote VIDD is essential to develop a therapeutic strategy to protect against MV-induced diaphragm weakness.
Although the molecular underpinnings that cause VIDD remain unclear, it is well established that prolonged MV results in accelerated proteolysis in the diaphragm [7] . Specifically, our laboratory has shown that MV-induced activation of calpain and the proteasome system in the diaphragm are associated with the breakdown of myofibrillar proteins [8] [9] [10] , and caspase-3 activity is associated with both contractile protein cleavage and apoptosis [8, 11] . In addition to these proteolytic pathways, autophagy is also activated in the diaphragm of both rodents and humans during prolonged MV [12, 13] . However, the role that autophagy plays in the development of VIDD remains unclear. In this regard, evidence suggests that increased autophagy can be a doubleedged sword. In theory, accelerated autophagy could produce protective or deleterious effects on skeletal muscle depending on the conditions [14, 15] . For example, MV-induced accelerated autophagy could promote diaphragm atrophy by eliminating healthy organelles and cytosolic proteins from muscle fibers [16] . In contrast, MV-induced autophagy could be protective by removing damaged mitochondria and aggregated proteins within diaphragm myofibers [16, 17] .
In addition to the downstream effects of accelerated autophagy on diaphragm muscle function, the upstream trigger promoting accelerated autophagy is unknown. In this regard, it has been demonstrated that MV-induced increases in ROS production in the diaphragm leads to activation of several proteases along with oxidative modification of muscle proteins making them more susceptible to degradation [18] [19] [20] [21] . The degradation of both cytosolic and myofibrillar proteins is a multistep process that requires the cooperation of several proteolytic components including the calpain, caspase-3, ubiquitin-proteasome and autophagy/lysosomal proteolytic systems [18] [19] [20] [21] . We have recently discovered that prevention of MV-induced increases in mitochondrial ROS emission is sufficient to prevent the activation of the calpain, caspase-3 and ubiquitin-proteasome proteolytic systems in the diaphragm during MV [22] . However, the role that mitochondrial ROS emission plays in activating the autophagy/lysosomal system in the diaphragm during prolonged MV remains unknown. Therefore, the goal of these experiments was twofold: (1) to determine the effects of accelerated autophagy on VIDD and; (2) to determine if MV-induced increases in mitochondrial ROS emission is required to increase the expression of autophagy biomarkers in the diaphragm. Specifically, we tested the hypothesis that accelerated autophagy is required for VIDD and that MV-induced increases in mitochondrial ROS emission promote autophagy gene expression and activate autophagy in the diaphragm.
Material and methods

Animals
Young adult (~6 month old) female Sprague-Dawley rats were used in these experiments. The Institutional Animal Care and Use Committee of the University of Florida approved these experiments.
Experimental design
To investigate the role that autophagy plays in VIDD we performed two separate experiments. Experiment 1. To test the hypothesis that increased autophagy is required for VIDD, we administered a dominant negative Atg5 (dnATG5) adeno-associated virus (AAV9) vector to the diaphragm to inhibit MV-induced autophagosome formation. Rats were randomly assigned to one of four experimental groups (n=10/group): (1) acutely anesthetized controls; animals treated with AAV9 expressing green fluorescent protein (GFP) (CON); (2) acutely anesthetized controls; animals treated with AAV9 expressing dnATG5-GFP (CON-dnATG5); (3) 12 h of MV; animals treated with AAV9 expressing GFP (MV); and (4) 12 h of MV; animals treated with AAV9 expressing dnATG5-GFP (MV-dnATG5). Primary dependent measures included the assessment of diaphragm cross-sectional area (CSA), contractile function, biomarkers of autophagy and biomarkers of oxidative stress.
Experiment 2. This experiment tested the hypothesis that increased mitochondrial ROS emission is required to promote autophagy gene expression and activate autophagy in the diaphragm of mechanically ventilated rats. Animals were assigned to one of three experimental groups (n=8/group): (1) an acutely anesthetized control group (CON); (2) a 12 h MV group (MV); and (3) a 12 h MV group treated with the mitochondria-targeted antioxidant SS-31 (MVSS). Dependent measures for Experiment 2 included the assessment of biomarkers of autophagy including electron microscopy, western blot, real-time polymerase chain reaction and activity assays.
2.2.1. Experimental protocol 2.2.1.1. Packaging and purification of recombinant AAV vectors. The dnATG5 plasmid was a gift from Roberta Gottlieb (Addgene plasmid #13096). We constructed the pTRUF12-dnATG5 plasmid by PCR amplifying the dnATG5 sequence into the SpeI and ClaI sites of pTRUF12. Verification of the appropriate fusion sequence was performed by DNA sequencing at the University of Florida DNA Sequencing Core Facility. The GFP expressing empty vector, pTRUF12 was used as a control plasmid. The rAAV pTRUF12-dnATG5 and pTRUF12 were generated, purified and tittered at the University of Florida Gene Therapy Center Vector Core Lab as previously described [23] . The conjugation of Atg12 to Atg5 is a required step in the elongation of the autophagosome [24, 25] . This mutated form of Atg5 is defective in its conjugation to Atg12, which is required for LC3 incorporation into the early autophagosomal structure, and thus inhibits autophagy at the level of autophagosome formation. Western blots for GFP were performed to verify the presence of the constructs in all animals (data not shown).
Surgical protocol for gene transduction.
To prevent MV-induced autophagy in the diaphragm we delivered an AAV vector containing dnATG5 to the costal diaphragm via direct injection. This technique is described in recent reports [13, 26] . Importantly, this method of gene transfer has been shown to effectively transduce the rat diaphragm with no adverse side effects [13, 26] . Animals were studied four weeks after AAV injection.
2.2.1.3. SS-31 administration. The mitochondria-targeted antioxidant SS-31 was dissolved in saline and delivered in a bolus (loading) dose (3 mg/kg, subcutaneous injection) 15 min before initiation of MV. A constant intravenous infusion (0.05 mg/kg/h) of SS-31 was maintained throughout MV. Previous work demonstrated that this dose of SS-31 in spontaneous breathing animals does not affect diaphragm CSA, force production or mitochondrial respiratory function [27] . In addition, we also determined that SS-31 administration in mechanically ventilated animals is sufficient to prevent diaphragm atrophy, contractile dysfunction, mitochondrial dysfunction and ROS production [27] .
2.2.1.4. Mechanical ventilation. Control animals were not exposed to MV and were acutely anesthetized with sodium pentobarbital (60 mg/ kg body weight intraperitoneally). MV animals were tracheostomized and mechanically ventilated with a pressure-controlled ventilator (Servo Ventilator 300, Siemens) for 12 h as previously reported [28] . The carotid artery was cannulated to permit the continuous measurement of blood pressure during the protocol. A venous catheter was inserted into the jugular vein for continuous infusion of sodium pentobarbital (~10 mg/kg/h) and fluid replacement. Body temperature was maintained at~37°C by use of a heating blanket and heart rate was monitored via lead II electrocardiograph.
2.2.1.5. Systemic and biological response to MV. Prior to the initiation of MV, no significant differences existed in body weight between the experimental groups. Importantly, 12 h of MV did not significantly alter body weight between groups (p < 0.05). In addition, heart rate (HR), systolic blood pressure (SBP), arterial partial pressures of O 2 (PaO 2 ), CO 2 (PaCO 2 ) and pH were all maintained relatively constant during MV and no significant differences existed between groups (Table 1 and [27] ). In addition, the colonic (body) temperature remained relatively constant (36-37°C) during MV. At the completion of the MV protocol, there was no visible indication of lung injury and no evidence of infection, indicating that our aseptic surgical technique was successful.
Biochemical measures 2.3.1. Western blot analysis
Diaphragm protein extracts were assayed as previously described [29] . Briefly, diaphragm tissues were homogenized 1:10 (wt/vol) in 5 mM Tris (pH 7.5) and 5 mM EDTA (pH 8.0) with a protease inhibitor cocktail (Sigma-Aldrich, St. Louis, MO) and centrifuged at 1500g for Table 1 Animal heart rates, systolic blood pressure, arterial blood gas tensions, and arterial pH at the completion of 12 h of mechanical ventilation. Values are means ± SE. Note that no significant differences existed between the experimental groups in any of these physiological variables.
Physiological variable MV MV-dnATG5
Heart rate 359 ± 12 367. 
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10 min at 4°C. Supernatant was collected and protein content was assessed by the Bradford method (Sigma-Aldrich). Proteins were separated via polyacrylamide gel electrophoresis. Membranes were probed for Beclin 1 (#3495), Atg12 (#4180), LC3B (#2775) (Cell Signaling Technology, Danvers, MA), Atg7 (NBP2-24682) (Novus Biologicals, Minneapolis, MN), p62 (ab56416), catalase (ab16731), PMP70 (ab3421) (Abcam, Cambridge, UK), cathepsin L (sc-6498) and spectrin (sc-48382). α-tubulin (sc-58667) (Santa Cruz Biotechnology, Dallas, TX) was also probed for as a loading control.
Real-time polymerase chain reaction
Total RNA was isolated from diaphragm tissue with TRIzol Reagent (Life Technologies, Carlsbad, CA). Total RNA (5 µg) was then reverse transcribed with the Superscript III First-Strand Synthesis System for RT-PCR (Life Technologies), using oligo(dT)20 primers. One microliter of cDNA was added to a 25 µl PCR reaction for real-time PCR using Taqman chemistry and the ABI StepOnePlus Real-Time PCR system (ABI, Foster City, CA) as previously described [29] . β-Glucuronidase was chosen as the reference gene based on previous work showing unchanged expression with our experimental manipulations [30, 31] . mRNA transcripts were assayed using predesigned rat primer and probe sequences commercially available from Applied Biosystems (Assays-onDemand).
Cathepsin L activity
Diaphragm muscle was homogenized 1:5 (wt/vol) in ice cold CL Buffer (provided in the kit). Samples were centrifuged at 1500g for 5 min at 4°C. Supernatant was collected and protein concentration was assayed via the Bradford method. Cathepsin L activity was measured fluorometrically according to the manufacturer's instructions (Abcam).
Measurement of in vitro diaphragmatic contractile properties
A muscle strip, including the tendinous attachments at the central tendon and rib cage was dissected from the midcostal region. The strip was suspended vertically between two lightweight Plexiglas clamps with one end connected to an isometric force transducer (model FT-03, Grass Instruments, Quincy, MA) within a jacketed tissue bath. The force output was recorded via a computerized data-acquisition system (Super Scope II, GW Instruments Somerville, MA). The muscle strip was stimulated along its entire length with platinum wire electrodes (modified S48 stimulator, Grass Instruments) by using supramaximal (~150%) stimulation voltage to determine the optimum contractile length (Lo). To measure the force frequency response each strip was stimulated supramaximally with 120-V pulses at 15-160 Hz [32] .
Mitochondrial respiration and ROS emission
Mitochondrial oxygen consumption and ROS emission were measured in isolated mitochondria from diaphragm muscle using previously described techniques [33] . Respiration was measured via polarography in water-jacketed respiration chambers maintained at 37°C (Hansatech Instruments, King's Lynn, UK). 5 mM pyruvate and 5 mM malate and 0.25 mM ADP were added to stimulate state 3 respiration. The RCR was calculated by dividing state 3 by state 4 respiration. Diaphragmatic mitochondrial ROS emission was determined using Amplex™ Red (Molecular Probes, Eugene, OR). Details of this assay have been described previously [33] . Mitochondrial ROS production was measured using the creatine kinase energy clamp technique to maintain respiration at steady state using previously described methods [34] .
Histological measures 2.4.1. Electron microscopy
Diaphragm muscle was fixed in a 4% paraformaldehyde solution in PBS. Samples were treated and prepared for electron microscopy examination by the University of Florida ICBR Electron Microscopy Core Lab. A Hitachi H-7000 TEM was used to acquire diaphragm images.
Immunogold labeling of catalase
Diaphragm muscle was fixed in a 4% paraformaldehyde solution in PBS. Samples were treated and prepared for examination of immunogold labeling of catalase, and were analyzed by the University of Florida ICBR Electron Microscopy Core Lab. Anti-catalase antibody was obtained from Abcam (ab6573). A FEI Spirit TEM operated at 120 kV was used to acquire diaphragm images.
Myofiber cross-sectional area
Sections from frozen diaphragm samples were cut at 10 µm using a cryotome (Shandon Inc., Pittsburgh, PA) and stained for dystrophin, myosin heavy chain (MHC) type I and MHC type IIa proteins for fiber cross-sectional area analysis (CSA) as described previously [28] . Images were acquired via a monochrome camera attached to an inverted fluorescent microscope (Axiovert 200, Xeiss). Diaphragm myofiber CSA was determined using Scion software (NIH).
LC3 immunohistochemistry
Sections from frozen diaphragm samples were cut at 10 µm using a cryotome. Diaphragm sections were blocked for an hour with 5% bovine serum albumin and 3% goat serum in PBS. LC3 primary (Cell Signaling Technology) and secondary (Alexa Fluro 488 goat anti-rabbit) reagents diluted in 1% bovine serum albumin [35] . Sections were mounted with vectashield mounting medium with dapi (Vector laboratories, Burlingame, CA). Images were acquired via a monochrome camera attached to an inverted fluorescent microscope (Axiovert 200, Xeiss).
Statistical analysis.
Comparisons between groups for each dependent variable were made by a one-way analysis of variance (ANOVA) and, when appropriate, a Tukey HSD (honestly significant difference) test was performed post-hoc. Significance was established at p < 0.05. Data are presented as means ± SEM. Statistical analysis was not performed on electron microscopy images due to the small sample size (n=2-4/group).
Results
dnATG5 diaphragm transduction ameliorates autophagic signaling
Preliminary studies were conducted to determine the appropriate administration of dnATG5 to reduce MV-induced autophagic signaling to basal levels. Our results confirm the effectiveness of our dosing protocol as MV resulted in a significant increase in the conjugation of Atg12-Atg5 (+188.5 ± 18.8%) and the activity of cathepsin L (+1.77 ± 0.24 fold), while MV animals that were administered dnATG5 showed no differences compared to CON animals ( Fig. 1A-B) . In addition, we assessed the mRNA expression of several mitochondrial proteins required for the regulation of mitophagy in skeletal muscle. These data demonstrate that MV results in a significant increase in the mRNA expression of PINK1 (+2.67 ± 0.61 fold), p62 (+4.11 ± 0.61 
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fold), Mul1 (+4.16 ± 0.59 fold), Nix (+1.72 ± 0.24 fold) and BNIP3 (+1.43 ± 0.07 fold) (Fig. 1C) . In the diaphragm of MV-dnATG5 animals, PINK1, Nix and BNIP3 did not differ from CON animals; however, p62 (+2.63 ± 0.43 fold) and Mul1 (+2.53 ± 0.29 fold) remained elevated in these animals compared to CON. Finally, our results also indicate that MV and MV-dnATG5 had no effect on the expression of Parkin in the diaphragm compared to CON animals.
Inhibition of MV-induced autophagy ameliorates VIDD
Twelve hours of MV resulted in a reduction in diaphragm specific force production at all stimulation frequencies (15-160 Hz; −21.3 ± 1.60%) and decreased myofiber CSA (Type I −32.7 ± 6.71; IIa −30.7 ± 6.25; IIb/x −39.3 ± 4.64%) compared to CON. Importantly, dnATG5 transduction in the diaphragm prior to MV was sufficient to attenuate MV-induced diaphragm contractile dysfunction at stimulation frequencies greater than 15 Hz and also prevented the MV-induced reduction in diaphragm myofiber CSA ( Fig. 2A-B) . In addition, no differences existed in diaphragm force production or muscle fiber size between CON and CON-dnATG5 animals.
Inhibition of autophagy prevents MV-induced autophagosome formation
Electron microscopy images were used to visualize changes in diaphragm ultrastructure and autophagosome formation. The 
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representative images shown in Fig. 3A -B illustrate that independent of MV, dnATG5 did not adversely affect the diaphragm. Specifically, these images show intact sarcomeres with no obvious abnormalities in the ultrastructure of the fibers. Fig. 3C depicts sample diaphragm images from MV animals. In these images, autophagic vesicles are visible within the diaphragm. Finally, Fig. 3D portrays images from MVdnATG5 animals; importantly, images from these animals appear to contain relatively few autophagosomes.
Effects of dnATG5 on diaphragm proteolytic activity
Evidence in cardiomyocytes suggests that a regulatory cross-talk exists between autophagy and other proteolytic systems [36] . Our data confirm that MV results in a significant increase in the activity of calpain (+142.9 ± 11.8%) and caspase-3 (+155.4 ± 10.5%), represented by the accumulation of the 145 kDa and 120 kDa breakdown products of spectrin, respectively (Fig. 4A-B) . In addition, prevention of increased autophagy in the diaphragm prevents the MV-induced activation of caspase-3. Our findings also confirm previous reports that prolonged MV results in increased mRNA expression of the muscle-specific E3 ligases MuRF1 (+9.34 ± 2.21 fold) and Atrogin-1/MaFbx (+4.83 ± 0.55 fold) in the diaphragm [10, 13, 37] . Note that dnATG5 diaphragm transduction did not influence the impact of prolonged MV on diaphragmatic expression of these E3 ligases (Fig. 4C-D) . In addition, prolonged MV resulted in significant increases in diaphragm mRNA expression of polyubiquitin (pUB) (+2.06 ± 0.29 fold) and the proteasome regulatory complex p28α (+1.79 ± 0.11 fold); these effects were also not impacted by transduction of dnATG5 in the diaphragm (Fig. 4E-F) .
Prevention of accelerated autophagy prevents MV-induced mitochondrial dysfunction and oxidative stress
The current study shows that MV results in increased diaphragm mitochondrial ROS emission (state 3: +1.64 ± 0.16 fold; state 4: +1.79 ± 0.19 fold) and a reduced respiratory control ratio (RCR) (−0.56 ± 0.02 fold) compared to CON animals ( Fig. 5A-C) . Reduced RCR in MV animals primarily occurred as a result of an increase in state 4 oxygen consumption (+1.24 ± 0.04 fold), as no significant differences existed in state 3 respiration between groups. Importantly, our 
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Free Radical Biology and Medicine 115 (2018) [179] [180] [181] [182] [183] [184] [185] [186] [187] [188] [189] [190] results also confirm that inhibition of autophagy in control animals did not impact mitochondrial function, as no differences existed between the CON and CON-dnATG5 groups in RCR or ROS emission. Importantly, animals in the MV-dnATG5 group were rescued from the MVinduced changes to these markers of oxidative stress and mitochondrial damage. The mechanism(s) to explain the protection against MV-induced oxidative stress in animals treated with the dnATG5 is unclear but could be linked the fact that accelerated autophagy has been shown to reduce cellular antioxidant capacity by autophagic removal of peroxisomes and a subsequent reduction in catalase [38] . Our data reveal that compared to both CON and dnATG5 animals, prolonged MV results in a significant reduction in catalase protein abundance in the diaphragm (−21.5 ± 8.12%), while no differences in catalase mRNA expression exist between groups (Fig. 6A-B) . To determine the effect of autophagy inhibition on peroxisome content, we measured the peroxisome membrane protein 70 (PMP70). Animals in the MV-dnATG5 group demonstrated a significant increase (+156.7 ± 22.4%) in PMP70 compared to all other groups (Fig. 6C) . Finally, immunogold labeling of catalase in the diaphragm was used to observe differences in catalase within the diaphragm muscle. Visual assessment of these images reveals a greater abundance of catalase in CON and MV animals treated with dnATG5 compared to MV animals (Fig. 6D ).
The mitochondrial peptide SS-31 reduces MV-induced autophagosome formation and preserves diaphragm morphology
Electron microscopy images were obtained to visualize alterations to diaphragm muscle fiber ultrastructure that occur as a result of prolonged MV. Fig. 7A depicts differences in the abundance of autophagic vacuoles between CON, MV and MVSS animals, while Figs. 7B and 7C images demonstrate differences between mitochondrial structure between the two groups, with MV resulting in the appearance of rounded mitochondria with a loss of cristae structure, which may be indicative of compromised mitochondrial function.
Delivery of a mitochondrial-targeted peptide (SS-31) prevents MVinduced biomarkers of autophagy in the diaphragm
Prolonged MV results in increased mRNA and protein expression of LC3 (+1.82 ± 0.30 fold), Atg7 (+2.16 ± 0.07 fold), Atg12 (+1.92 ± 0.29 fold), Beclin 1 (+1.91 ± 0.30 fold) and p62 
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Free Radical Biology and Medicine 115 (2018) [179] [180] [181] [182] [183] [184] [185] [186] [187] [188] [189] [190] (+2.23 ± 0.34 fold) in the diaphragm compared to CON, which is attenuated in animals treated with SS-31 (Fig. 8A ). In addition, MV results in the appearance of LC3 punctae in diaphragm muscle fibers (+26.9 ± 3.10 fold), and administration of SS-31 to mechanically ventilated animals was sufficient to diminish the formation of LC3 punctae (Fig. 8B) . Finally, assessment of the expression of cathepsin B, D and L in the diaphragm revealed an increase in mRNA expression of cathepsin B (+2.64 ± 0.27 fold) and cathepsin L (+8.44 ± 1.56 fold) in animals exposed to prolonged MV, which was attenuated in MVSS animals (Fig. 8C ). In addition, following prolonged MV there was a significant increase in the activity of cathepsin L in the diaphragm (+202.3 ± 35.15%) compared to CON, which was prevented by treating animals with SS-31 (Fig. 8D ).
Discussion
Inhibition of MV-induced autophagy prevents VIDD
Autophagy is a catabolic process that involves lysosomal degradation of cytosolic proteins and organelles. In general, autophagy occurs on a continuous basis at low levels in muscle tissue and is important for maintaining the breakdown of dysfunctional cytosolic material [39, 40] . Specifically, studies show that basal levels of autophagy are required for normal muscle function, and that deletion of specific autophagy genes can result in significant functional deficits [41, 42] . However, under pathological conditions autophagy can be greatly increased to promote a deleterious rate of protein removal. Indeed, pathologically high levels 
A.J. Smuder et al.
Free Radical Biology and Medicine 115 (2018) [179] [180] [181] [182] [183] [184] [185] [186] [187] [188] [189] [190] of autophagy can result in the elimination of vital cellular organelles and proteins, and potential cross-talk between other proteolytic systems to increase cell death and promote muscle atrophy [43] . In this regard, MV results in increased autophagosome formation and increased expression of autophagy-related genes in the diaphragm, and is associated with muscle weakness [13] . Indeed, our data confirm that autophagy is required for VIDD, as inhibition of autophagy was sufficient to prevent diaphragm muscle atrophy and contractile dysfunction in rats after 12 h of MV.
Effects of autophagy inhibition on diaphragm proteolysis
The autophagy/lysosomal system has been shown to participate in cross-talk with the calpain, caspase-3 and proteasome degradation pathways [44] [45] [46] [47] . Specifically, calpain activation can act as a negative regulator of autophagy by cleaving Atg5 and preventing the conjugation of Atg5-Atg12 [44, 45, 48] . In addition, caspase-3 activity may also play a role as a negative regulator of autophagy by shifting the signaling of Beclin-1 from autophagic protein degradation to apoptotic protein degradation [46, 49] . Independent of these potential mechanisms, our laboratory has established that increased diaphragm ROS production is an essential upstream trigger to activate both the calpain and caspase-3 proteolytic systems [50] . Moreover, oxidative modification of myofibrillar proteins increases their susceptibility to degradation by calpain and caspase-3, which promotes increased proteolysis and skeletal muscle dysfunction [9] . Therefore, inhibiting autophagy may prevent calpain and caspase-3-dependent proteolysis via the reduction in oxidative damage to the diaphragm. Our data supports this hypothesis as autophagy inhibition downregulated calpain and caspase-3 activity rather than increasing it.
In contrast to the finding that inhibition of autophagy blunted the MV-induced activation of both calpain and caspase-3 in the diaphragm, our results reveal that biomarkers of the proteasome system remained elevated in the diaphragms of MV-dnATG5 animals. This observation is comparable to previous reports indicating that pharmacological inhibition of autophagy does not prevent increased proteasome activity in the heart [47, 51] . This finding is consistent with the concept that, in the absence of accelerated autophagy, the proteasome system is upregulated in a compensatory manner to degrade damaged proteins in the diaphragm during MV. Finally, while evidence from our lab has shown Free Radical Biology and Medicine 115 (2018) [179] [180] [181] [182] [183] [184] [185] [186] [187] [188] [189] [190] that calpain and caspase-3 activity are required for VIDD [8] , we have also demonstrated that the ubiquitin proteasome system does not significantly contribute to MV-induced diaphragm weakness [10] . Based on this previous report and the current findings, activation of the ubiquitin proteasome system when autophagy is inhibited should not affect the diaphragm during MV.
Mitochondrial ROS emission promotes autophagosome formation in the diaphragm
The autophagy/lysosomal system is activated in numerous conditions that promote muscle wasting (i.e. denervation, hind-limb immobilization, chemotherapy etc.) [14, 15] . During each of these conditions, increased generation of ROS results in oxidative stress and organelle damage within skeletal muscle myofibers [52] . Moreover, increased cellular ROS production results in the increased expression of autophagy-related genes and the activation of autophagy [53] [54] [55] . While basal autophagy is necessary for cell survival, excessive autophagy is associated with muscle atrophy [56] [57] [58] . In reference to VIDD, it is established that prolonged ventilator support results in increased ROS production in the diaphragm along with increased expression of autophagy genes [12, 27, 29, 33, 59] . The current study provides evidence that MV-induced mitochondrial ROS production is a requirement for the MV-induced increase in the expression of key autophagy proteins in the diaphragm. Indeed, administration of the mitochondrialtargeted antioxidant peptide SS-31 prevented both the MV-induced expression of specific biomarkers of autophagy and the increase in autophagosome formation within the diaphragm. Coupled with our previous work, these findings establish a significant role for MV-induced mitochondrial ROS production in the regulation of four key proteolytic pathways (e.g. calpain, caspase-3, proteasome and autophagy) in the diaphragm during prolonged MV.
MV-induced autophagy is required for diaphragm mitochondrial dysfunction and oxidative stress
Paradoxical to our finding that prevention of MV-induced increases in mitochondrial ROS production (via the antioxidant peptide SS-31) is sufficient to prevent MV-induced increases in biomarkers of autophagy in the diaphragm, our data also reveal that selective inhibition of autophagy via dnATG5 prevents both MV-induced mitochondrial ROS emission and oxidative stress. These results suggest that a regulatory cross-talk exists between oxidative stress and autophagy, whereby increased autophagy is stimulated by oxidative stress, resulting in further increases in both ROS production and autophagy. In this regard, similar results have been reported in other cell types when autophagy is inhibited [38, 60] . Specifically, it has been predicted that autophagy upregulation results in the selective degradation of the endogenous antioxidant catalase via elimination of peroxisomes and mitochondria, causing an increase in cellular ROS [38] . Therefore, autophagy inhibition may reduce ROS production and prevent a positive-feedback loop where increased autophagy is stimulated by oxidative stress, resulting in further increases in ROS and autophagy. Our results corroborate this finding as inhibiting autophagy prevented the degradation of catalase and resulted in increased expression of PMP70 within the diaphragm.
Conclusions
In summary, these experiments provide the first evidence that autophagy plays a required role in the development VIDD. Further, our work reveals a novel cross-talk between autophagy and oxidative stress. These studies provide further insight into the mechanisms responsible for VIDD and demonstrate the use of mitochondrial-targeted antioxidants as a potential therapy to prevent MV-induced diaphragm proteolysis.
